A Pilot Study of Avelumab and Stereotactic Ablative Radiotherapy in Non-responding and Progressing NSCLC Patients Previously Treated With a PD-1 Inhibitor
Phase of Trial: Phase 0
Latest Information Update: 04 Oct 2017
At a glance
- Drugs Avelumab (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 28 Sep 2017 Status changed from not yet recruiting to recruiting.
- 14 Jun 2017 Planned initiation date changed from 1 Jun 2017 to 1 Jul 2017.
- 25 May 2017 New trial record